Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any word on the mediation ??
So far its been a one way street,
ALL GIVE by RLF, and ALL TAKE by Neuro
yes, TB, It must be like all the other numerous law firms
that have filed suit against Neuro for fraud.
Suppose none of these numerous law firms have any clients either ???
Especially considering all the losses on almost every shareholder
or former shareholder....
Hot News Out Today On NRXP..........The Elephant in the Court Room
https://www.prnewswire.com/news-releases/nrxp-investors-have-opportunity-to-lead-nrx-pharmaceuticals-inc-securities-fraud-lawsuit-301486155.html
Another Fraud Lawsuit Against Neuro and Co
Pegs1......
Thanks, Its been all over the net... and its a shame the
government regulators, according to this evidence, are bought
and paid for by those that they regulate.
MSM of course will not report things like this...even with video evidence.
Its seems like an alternate universe that we live in often where
black is white, and white is black.
One Example ...Seems today about 97 percent of USA antibiotics are mfg in the great country of China. Seems we have no stomach for it.
I hope the EU will approve and promote aviptadil for RLF, if the FDA and the US are unwilling to do so. Sometimes I wonder if RLF can team up with a Swiss pharma co....like NOVARTIS or a HOFFMAN LAROCHE to speed things up.
TurdBlossom.... ... .. suppose my thoughts would fall somewhere in the similar sentiment of posters like, Wong, Old James, Woodcrest, Bogo, Diane, Steve, etc. A lot of folks that have followed this for a long time, and many, here and on other boards have expressed some very thoughtful intelligent posts.
And yourself TB, what are your thoughts ???
PW, At this time, its beyond my sphere of comprehension and understanding to think that NRX can be trusted with any new signed or new verbal agreements going forward.
Why would any group suddenly trust some entity/person that has not honored previous agreements and commitments ??? Seems like its been all give for RLF and....... all take for NRX.
Thanks for laying out the format for next week !!!
Big Dump today on light volume.
That does not look very bullish to me.
From another place where posts are often deleted much later.
Seems this jj is very active again............
........................................
Jonathan Javitt 13 hours ago @MERICA
So you are referring to a document stating that a hospital brought in an a doctor who was not a licensed investigator without telling the sponsor and we reported that to FDA. Also, that we published the statistically significant difference on primary endpoint and on survival if you control for site of care (tertiary care vs. regional hospitals). Everyone who looks at the published data can see that two regional hospitals had zero survival in randomized patients. In the midst of the December 2020 surge. The data obtained in the study to which you refer were the same data that NIH used to select ZYESAMI for ACTIV-3b in which ZYESAMI is the only remaining investigational medicine. Now NIH is taking the medicine we have successfully manufactured to The EU, the UK, Brazil, and and Scandinavia with the active participation of those governments. As Dr. Francis Collins said to the public, NIH started with a pool of 600 candidate medicines. ZYESAMI was one of a handful selected for ACTIV.
This week you saw an important report from the NIH DSMB based on enrollment of 448 patients, funded by the US Government. We continue to provide FDA with additional data in support of safety and efficacy and are delighted by this week’s news of the appointment of a Senate-confirmed FDA commissioner.
We are likely the smallest biotech company ever to make it to the finals. You should expect us to keep advancing our investigational medicines in the interests of patients and shareholders. Don’t expect 100% pass completion. It doesn’t happen in the Superbowl and it doesn’t happen in biotech.
......................................
AND BY THAT...................
Jonathan Javitt 20 hours ago
@MERICA
Unlicensed people?
What are you talking about?
.........................................
Some Great posters replying to these comments also....
Has jjs legal team let him out of the box to speak
on public BBs. ????? Is this cause the stock is dropping again ?
changes....All great points...thanks for sharing.
2/12 Robbins Geller Rudman & Dowd Lawfirm Update....
https://www.marketscreener.com/quote/stock/NRX-PHARMACEUTICALS-INC-38908842/news/NOTICE-Investors-in-NRx-Pharmaceuticals-Inc-with-Substantial-Losses-Have-Opportunity-to-Lead-Clas-38272928/
Good Luck and God Bless
walker.....
Great Find....all the thanks to you for sharing....
quick summary.......
...."may have better neutralizing ability"......
Yep, it MIGHT WORK...
.........."has unique potential"..........
Yes, ....it MIGHT WORK..........
Sounds like a desperation bit of buts, mights, maybes, news to me..............
No mention of the elephant in the court room.
PW, yes, agreed, and I suspect that there will be considerable amount of time doing depositions under oath. Too many conflicting statements, news releases, and activities for some over at NRX to try and keep from getting tangled up in the courtroom. Lots of lawyers will be looking at this and I do not believe any good judge will be fooled for a New York minute.
PW, thanks for sharing the interesting thoughts.
https://www.findlaw.com/litigation/filing-a-lawsuit/personal-jurisdiction-how-to-determine-where-a-person-can-be.html
I seem to think/believe that the CA was signed personally and not
as an officer of any company, as NRXP did not even exist, at least in its present public form with a BOD.
Thinking about it a little, and with jjs self admitted employment all over the map, at a bunch of unnamed "successful" biopharma startups, and named BP companies, like Merck, Allergan, Pharmacia, Novartis, and Pfizer, not to mention other such specifically named like, IT, etc and unnamed awards/accomplishments....
I gotta wonder why a guy can not remain in one place with any number of great companies for any length of time, especially if he is such a fantastic genius hot shot, .....at least in his own mind. Surely one of those companies would have a top slot for a guy like that. So, Gotta Ask Why not ???
Sure seems like to me and that with neuro, and the large number of lawsuits, the CA violations, the family payment involvement, the stock price disaster, and the failed FDA approvals, along with still no mediation or desire for it, ....that there is something very very different than all the other fabulous professed success stories.
PW / VF, thank you both for the clarity and the link.
Greatly appreciated again and very helpful.
To me, the NRXP story seems to keep spinning wilder and almost into the world of the bizzaro and unbelievable, except its real.
Someone is pretty far out in space and I do not think its RLF.
PW, I am with you on this. There was nothing published anywhere that I read or saw about the 25 Million in new stock issued as being with restricted usage. Unless it is restricted and not publicly shared, which might or could be some type of SEC violation.
VF, you are an intelligent person, but your constant cryptic short screaming statements in all caps and without links leave a lot to the be desired in the way of good communication.
I understand this is your opinion and we all have one.
It would be fantastic if you would share the specific links to the new court filings you refer to.
Is it a case of perhaps that there might be something there besides just a bit of arrogance ?
Especially when it comes to completely denying any responsibility for any problems .........
https://www.verywellmind.com/what-is-a-psychopath-5025217
choo choo, yes agreed. Suspect there are very few that
have made money on neuro, except for possibly jj and son, or a very few that bailed in the upper double digits and ran away.
Tempting to buy back in, but difficult to do so with the murky track
record thats anything but clear, and numerous serious legal open issues, very questionable PRs, and the like. Not good for a very young new company that was just hatched.
Gotta wonder if the 25 mill is for managmt/ee payroll, a lengthy legal battle, legal fees, fines, and settlements, to fund some other new unrelated project, or for a bigger legitimate cooperative aviptadil/zyesami study in conjunction with RLF.
PW, thanks for sharing. Greatly appreciated.
Walker, yes, it sure looks like neuro failed to deliver
on all the big talk and pr, on following the CA, and even SEC rules.
Yes, its been one disappointment and failure after another with lack of FDA approvals, law suits galore, and until there are some real FDA approvals and or solid working agreements/real cooperation with RLF, settlement of the law suits, these lower lows many continue, IMHO.
I will be surprised if any meaningful mediation occurs and I think neuro has been backed into a corner of its own making, with no escape. All IMHO.
Bree Life looks DOA after the deal with yet unapproved NVAX for up to 10 mil units in Israel, and neuro seems unwilling or unable to end its standoff with RLF. Perhaps way down the road they may get some orders, if Covid is even still around.
I think we investors have all been very disappointed, and I wish good luck to everyone especially RLF and even the mistake plagued NEURO.
I hope NRX makes lotsa $$$$ on something cause they might need it to pay large potential judgements and avoid CH 7 or 11.
Walker, thanks for sharing...
Gotta wonder how much of this 25 mil will be for legal fees, SEC judgements, and the like.
Interesting that Neuro STILL does not acknowledge any partnership agreement with RLF in their news releases, like they never violated the agreement in so many ways, or the agreement does not even exist.
Also no public mention by neuro of all the lawsuits by all the various law firms, like the legal / SEC problems do not exist.
At the moment, the stock is back to a 52 week low of $2.80,
Not good sign.
https://www.theblaze.com/op-ed/horowitz-whistleblowers-share-dod-medical-data-that-blows-vaccine-safety-debate-wide-open
VACCINE SAFETY IS FICTION UNLESS YOU BELIEVE IN POLITICAL SCIENCE
TO SOLVE THE COVID PROBLEM........
Aside from the spike in miscarriage diagnoses (ICD code O03 for spontaneous abortions), there was an almost 300% increase in cancer diagnoses (from a five-year average of 38,700 per year to 114,645 in the first 11 months of 2021). There was also a 1,000% increase in diagnosis codes for neurological issues, which increased from a baseline average of 82,000 to 863,000!
Some other numbers he did not mention at the hearing but gave to me in the interview are the following:
myocardial infarction –269% increase
Bell’s palsy – 291% increase
congenital malformations (for children of military personnel) – 156% increase
female infertility – 471% increase
pulmonary embolisms – 467% increase
All these numbers are among the ambulatory visits because those are where the vast number of diagnoses in the military occur. However, Renz did say the increases were indicated in the hospitalized patients as well. I have seen one of the sworn declarations from one of the military doctors, and it states as follows, “It is my professional opinion that the major increases incidences of the above discussed instances of miscarriages, cancers, and disease were due to COVID-19 ‘vaccinations.'"
For his part, Sen. Ron Johnson said at the Monday hearing that he put DOD on notice that it better not delete any of the data. “The Department of Defense, the Biden administration is on notice they must preserve these records and this must be investigated,” said Johnson. Renz testified at the hearing that some of the myocarditis data was slid backwards since the doctors originally downloaded it last year.
Even if somehow these earth-shattering increases have nothing to do with the vaccines, isn’t it important that our government investigate what appears to be a catastrophic decline in the health of our active-duty fighting force? After all, the DMED data was designed for this very purpose. “A person can do a research paper just on this data alone,” said one of the whistleblowers I spoke to. “It was designed for this very purpose. The amount of data points you could query is nearly unlimited.”
The bottom line according to Renz is that the onus of proof is on the government, not on the military personnel and citizens being forced to take the shots. If the manufacturers are exempt from liability for government coercion to use their product, and the only pharmacological safety data we have is completely ignored, then where is the recourse of the people to redress safety concerns? In the opinion of the Ohio attorney, if the shots are safe and effective, then the Pentagon should have no problem explaining the source of these gargantuan increases in instances of numerous illnesses. Transparency is the most potent cure of a pandemic of secrecy.
other big reasons for a safe effective therapeutic like
AVIPTADIL AND OR ZYESAMI.
https://citizenfreepress.com/breaking/dr-robert-malone-is-suing-washington-post/
Dr Malone is the patented inventor of the mRNA gene therapy technology and opposes the VAXX
Time for approval of a safe effective med like AVIPTADIL
Red...You may have lots of opportunity to add, and good luck, as
even Israel is NOT buying jjs Brilife , but yet UNAPPROVED Novavax.
https://www.jpost.com/breaking-news/article-694872
The Israeli government has agreed a deal with US-based biotech company Novavax to buy five million COVID-19 vaccine doses, the Health Ministry announced on Friday.
The Novavax vaccines, expected to arrive in Israel over the next few months, are yet to receive the nod of approval from the US Food and Drug Administration (FDA). As part of the deal, Israel has the option to purchase an extra five million vaccine doses.
Personally, I feel the winds are more favorable behind RLF, instead of NRX with all its legal issues.
https://thenationalpulse.com/2022/01/27/nyt-admits-unvaccinated-had-lower-covid-infection-rate/
AVIPTADIL and or ZYESAMI is the answer
https://www.thegatewaypundit.com/2022/01/never-seen-many-deaths-around-500-600-increase-funeral-director-uk-reveals-increasing-number-death-vaccinated-young-adults/
Just one professional reporting like many thousands of others, that have evidence suppressed or ignored about dangerous deadly JABS, all in the name of political science and not science.
The world needs a safe med like aviptadil and zyesami.
https://www.zerohedge.com/covid-19/covid-19-can-be-stopped-without-massive-vaccination-dr-peter-mccullough
This man is one of the most published experts and highly qualified doctors on the planet........
Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals.
https://covid19.onedaymd.com/2021/11/dr-peter-mccullough-early-treatment.html
https://www.heartplace.com/dr-peter-a-mccullough
DR PETER A. McCULLOUGH, MD, MPH, FACC, FCCP, FAHA, FNKF, FNLA, FCRSA
Perhaps RELIEF should look at adding the doctor to their board for another ringing endorsement of the safe effective aviptadil
https://rumble.com/search/video?q=vaccine%20problems%20and%20deaths
Countless doctors, experts, data, deaths, side effects, and dangers, of the clot shot are out there, which only shows the absolute critical need for a safe effective therapeutic like RLF aviptadil, and or zyesami.
Red, I really have no expectations on the warrants, and I have not followed them, thank goodness. To me, at least, right now, to answer your question, it seems like it could be a lotto ticket, all IMHO.
What are your expectations might be a better question ??
https://stockcharts.com/h-sc/ui?s=NRXP&p=D&b=5&g=0&id=p45922685032
Technically this does not look good, IMHO. ....Back in the 2's.
https://ir.nrxpharma.com/news-events/press-releases/detail/115/nrx-announces-publication-of-initial-findings-of-brilife
Phase 2 test results of, lucky number, 13 whole people, may and might be the luck needed to roll this out to BILLIONS in profits for a company caught up in plenty of legal problems.
https://en-volve.com/2022/01/26/massive-ama-study-confirms-potential-deadly-risks-of-vaccines-as-biden-admin-pushed-for-mandates/
Those radical numerous folks over at the AMA seem to disagree with Mr Ouchee. Do you suppose Tony could make a another mistake, after changing his positions countless times so far ?
Should he be in charge even ?
Looks like Aviptadil/Zyesami should be an easy no brainer approval.
Senator Johnson on Cancer Numbers Exploding in the JABBED / VAXXED
https://citizenfreepress.com/breaking/senator-ron-johnson-vaccine-hearing-cancer-numbers-are-exploding/
Another reason for approval of a safe effective medication like
aviptadil and or zyesami. The world needs it now.
https://citizenfreepress.com/breaking/watch-live-senator-johnson-holds-covid-truth-hearing-with-top-doctors/
Heart problems, paralysis, blood clots, cancer....
Why not approval for a safe med like aviptadil/zyesami ??
I would really like to see jj put his own money into a significant amount of NRX stock bought at market prices.
Interesting analogy with the "hat trick" prsentation.
It might even help a few hockey players to buy in, but
its difficult not to consider with all the
EXPERIENCED people on the management page, and all the
EXPERIENCED people listed on the board, as to how one
company could so quickly accumulate so many lawsuits
and lawyers probing into NRX for legal issues.
https://stockcharts.com/h-sc/ui?s=NRXP&p=D&b=5&g=0&id=p38879565319
technicals not lookin very good here right at the moment, another new low. Could the 2's be in the cards ?????
Sure would be nice if NRX would break out the two lines of business
between the VAX and AVIPTADIL/ZYESAMI on the F/S.
Very difficult/impossible to follow what is going on with that in the F/S for the two completely different lines of business.